Apyx Medical Corporation Common Stock
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
APYX Overview
Sector |
Health Care |
Industry |
Medical/Dental Instruments |
Previous Close |
$5.9600 |
Previous Close Volume |
153250 |
Latest News
-
RENUVION NAMED #1 TRUSTED BODY CONTOURING TECHNOLOGY BY DOCTORS*
August 13, 2024
13 Aug 2024 08:17:39
https://apyxmedical.com/renuvion-named-1-trusted-body-contouring-technology-by-doctors/
- APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON AUGUST 8, 2024 July 25, 2024 25 Jul 2024 08:32:40
- APYX MEDICAL CORPORATION LAUNCHES THE “RENEWING LIVES” GIVE-BACK CAMPAIGN PROVIDING TREATMENTS WITH RENUVION TO BENEFIT PHYSICAL APPEARANCE AND MENTAL HEALTH June 26, 2024 26 Jun 2024 07:32:40
- APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS; REAFFIRMS FULL YEAR 2024 FINANCIAL OUTLOOK May 9, 2024 09 May 2024 07:17:40
-
APYX MEDICAL CORPORATION ANNOUNCES BOARD LEADERSHIP TRANSITION
May 9, 2024
09 May 2024 07:02:41
https://apyxmedical.com/apyx-medical-corporation-announces-board-leadership-transition/
- APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2024 FINANCIAL RESULTS ON MAY 9, 2024 April 25, 2024 25 Apr 2024 07:32:46
- APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS’ SUMMIT April 11, 2024 11 Apr 2024 08:02:47
- APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS; INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK March 21, 2024 21 Mar 2024 11:32:47
- APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY (AACS) SCIENTIFIC MEETING February 21, 2024 21 Feb 2024 07:32:47
- APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY January 22, 2024 22 Jan 2024 07:32:47
-
APYX MEDICAL CORPORATION APPOINTS MATTHEW HILL AS CHIEF FINANCIAL OFFICER
November 28, 2023
28 Nov 2023 09:15:17
https://apyxmedical.com/apyx-medical-corporation-appoints-matthew-hill-as-chief-financial-officer/